Farnesyltransferase Inhibitors of Microbial Origins in Cancer Therapy

Jingxuan Pan; Sai Ching Jim Yeung

doi:10.1002/9780470626528.ch16

Farnesyltransferase Inhibitors of Microbial Origins in Cancer Therapy

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Original language	English (US)
Title of host publication	Emerging Cancer Therapy
Subtitle of host publication	Microbial Approaches and Biotechnological Tools
Publisher	John Wiley and Sons
Pages	367-378
Number of pages	12
ISBN (Print)	9780470444672
DOIs	https://doi.org/10.1002/9780470626528.ch16
State	Published - Aug 18 2010

Keywords

FTIs inducing apoptosis and autophagy in cancer cells - mechanisms involving disruption of farnesylation of farnesylated proteins
Farnesyltransferase inhibitors - of microbial origins in cancer therapy
Manumycin, in vivo activity against human cancer cell lines - in xenograft models

ASJC Scopus subject areas

General Chemical Engineering

Access to Document

10.1002/9780470626528.ch16

Cite this

@inbook{839be275b5eb42e196d3199206cc8a39,

title = "Farnesyltransferase Inhibitors of Microbial Origins in Cancer Therapy",

keywords = "FTIs inducing apoptosis and autophagy in cancer cells - mechanisms involving disruption of farnesylation of farnesylated proteins, Farnesyltransferase inhibitors - of microbial origins in cancer therapy, Manumycin, in vivo activity against human cancer cell lines - in xenograft models",

author = "Jingxuan Pan and Yeung, {Sai Ching Jim}",

year = "2010",

month = aug,

day = "18",

doi = "10.1002/9780470626528.ch16",

language = "English (US)",

isbn = "9780470444672",

pages = "367--378",

booktitle = "Emerging Cancer Therapy",

publisher = "John Wiley and Sons",

}

TY - CHAP

T1 - Farnesyltransferase Inhibitors of Microbial Origins in Cancer Therapy

AU - Pan, Jingxuan

AU - Yeung, Sai Ching Jim

PY - 2010/8/18

Y1 - 2010/8/18

KW - FTIs inducing apoptosis and autophagy in cancer cells - mechanisms involving disruption of farnesylation of farnesylated proteins

KW - Farnesyltransferase inhibitors - of microbial origins in cancer therapy

KW - Manumycin, in vivo activity against human cancer cell lines - in xenograft models

UR - http://www.scopus.com/inward/record.url?scp=84886827925&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886827925&partnerID=8YFLogxK

U2 - 10.1002/9780470626528.ch16

DO - 10.1002/9780470626528.ch16

M3 - Chapter

AN - SCOPUS:84886827925

SN - 9780470444672

SP - 367

EP - 378

BT - Emerging Cancer Therapy

PB - John Wiley and Sons

ER -

Farnesyltransferase Inhibitors of Microbial Origins in Cancer Therapy

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this